Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $569.60 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $180.85 | 11 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $126.77 | 9 | $0 (2022) |
| AbbVie Inc. | $113.08 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $39.92 | 2 | $0 (2021) |
| Gilead Sciences, Inc. | $37.64 | 2 | $0 (2023) |
| CSL Behring | $35.32 | 2 | $0 (2022) |
| Allergan Inc. | $21.48 | 1 | $0 (2017) |
| Grifols USA, LLC | $14.54 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $131.93 | 2 | AbbVie Inc. ($113.08) |
| 2022 | $67.02 | 4 | AstraZeneca Pharmaceuticals LP ($31.90) |
| 2021 | $159.14 | 8 | PFIZER INC. ($83.81) |
| 2020 | $25.89 | 2 | AstraZeneca Pharmaceuticals LP ($25.89) |
| 2019 | $44.63 | 3 | PFIZER INC. ($44.63) |
| 2018 | $66.79 | 5 | AstraZeneca Pharmaceuticals LP ($38.09) |
| 2017 | $74.20 | 5 | PFIZER INC. ($23.71) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $113.08 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 05/11/2022 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Immunology | ||||||
| 03/22/2022 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 03/09/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/16/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.79 | General |
| 11/04/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/13/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| Category: Cardiovascular | ||||||
| 07/15/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/20/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/18/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| Category: Cardiovascular | ||||||
| 10/15/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/22/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/16/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/07/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/19/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 443 | 472 | $702,622 | $60,354 |
| 2022 | 4 | 465 | 495 | $731,314 | $70,160 |
| 2021 | 4 | 588 | 619 | $933,989 | $86,610 |
| 2020 | 4 | 548 | 585 | $877,227 | $78,232 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 290 | 310 | $527,298 | $45,370 | 8.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 129 | 138 | $157,108 | $13,610 | 8.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 24 | 24 | $18,216 | $1,375 | 7.5% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 331 | 360 | $594,534 | $58,051 | 9.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 59 | 60 | $66,150 | $6,256 | 9.5% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 64 | 64 | $47,409 | $3,668 | 7.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 11 | $23,221 | $2,184 | 9.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 442 | 472 | $778,328 | $72,688 | 9.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 71 | 72 | $79,416 | $7,529 | 9.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 60 | 60 | $44,580 | $3,755 | 8.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 15 | 15 | $31,665 | $2,638 | 8.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 403 | 430 | $709,070 | $63,878 | 9.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 69 | 75 | $82,725 | $7,417 | 9.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 18 | 19 | $40,109 | $3,615 | 9.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 58 | 61 | $45,323 | $3,322 | 7.3% |
About Dr. Mohammad Chelehmalzadeh, M.D
Dr. Mohammad Chelehmalzadeh, M.D is a Family Medicine healthcare provider based in Crosby, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902098460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Chelehmalzadeh, M.D has received a total of $569.60 in payments from pharmaceutical and medical device companies, with $131.93 received in 2023. These payments were reported across 29 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($569.60).
As a Medicare-enrolled provider, Chelehmalzadeh has provided services to 2,044 Medicare beneficiaries, totaling 2,171 services with total Medicare billing of $295,357. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Emergency Medical Services
- Location Crosby, MN
- Active Since 08/17/2007
- Last Updated 01/27/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902098460
Products in Payments
- ELIQUIS (Drug) $192.07
- BRILINTA (Drug) $126.77
- QULIPTA (Drug) $113.08
- Kcentra (Biological) $35.32
- CHANTIX (Drug) $28.70
- TEFLARO (Drug) $21.48
- HyperRAB (Biological) $14.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Crosby
Dr. Lacey Runninghawk Stawarski, Md, MD
Family Medicine — Payments: $2,674
Dr. Robert Roach, D.o, D.O
Family Medicine — Payments: $1,112
Dr. Camille Lang, M.d, M.D
Family Medicine — Payments: $1,025
Dr. Mark Bostrom, Do, DO
Family Medicine — Payments: $128.74
Terry May, Md, MD
Family Medicine — Payments: $108.50
Dr. Kristin Elliott, Md, MD
Family Medicine — Payments: $90.74